Yassin Taher/ LinkedIn
May 29, 2026, 09:53
Yassin Taher: Recognizing Clonal Eosinophilic Disorders in Pediatric Hypereosinophilic Syndrome
Yassin Taher, Pediatric Oncology Consultant at Children’s Cancer Hospital, shared a post on LinkedIn:
“Pediatric Hypereosinophilic Syndrome (HES) can mimic infection, autoimmune disease, lymphoma, or primary immunologic disorders.
I created this high-yield visual summary to simplify:
- Classification
- Diagnostic approach
- Molecular testing
- Organ involvement
- Modern targeted therapies
Key takeaway: Always evaluate persistent eosinophilia with evidence of organ dysfunction for possible clonal eosinophilic disorders, particularly FIP1L1–PDGFRA–associated disease due to its dramatic response to imatinib.”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026
-
Jul 13, 2026, 17:12Santagata Davide: A Great Session and an Incredible Opportunity to Present Our Research at ISTH 2026
-
Jul 13, 2026, 16:26Real-World Data Across Time Reveal Important Advances in Hemophilia Treatment – ATHN
-
Jul 13, 2026, 16:19Mary Cushman: Celebrating Our Incredible ISTH Council Members in Paris
-
Jul 13, 2026, 16:17Wolfgang Miesbach: Gene Therapy Shows Promising Early Results in Adolescents With Hemophilia B at ISTH 2026